Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C
Clinical trial NCT01448044 · COMPLETED
Trial details
- NCT number
- NCT01448044
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2013-10-01
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.